PuraPharm Corp. Ltd. (HK:1498) has released an update.
PuraPharm Corporation Limited is set to hold a Board meeting on August 28, 2024, to discuss the company’s interim results for the first half of the year and consider declaring an interim dividend. The meeting will involve key executive and non-executive members, including Chairman and Executive Director Chan Yu Ling, Abraham. This could be of interest to shareholders and potential investors as it may influence the company’s stock performance.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.
